-
Featured
Nerve Transfer Boosts Recovery After Brachial Plexus Injury
For patients with brachial plexus injuries, a Mass General neurosurgeon is innovating nerve transfers that can restore function to paralyzed arms.
-
Featured
How Liquid Biopsy Could Improve Brain Tumor Treatment and Diagnoses
Mass General doctors are developing a liquid biopsy for brain tumors to reduce the need for invasive tissue biopsies.
-
Featured
Surviving Gliomas Through Antibodies and Vaccination
Immunotherapy for glioma is under active investigation, but tumor-associated immunosuppression is a major obstacle. A Mass General team studied an investigational monoclonal antibody in mice with glioma, alone and in combination with tumor cell vaccination.
-
New Tool Identifies Risk of Neurotoxicity After CAR T-cell Therapy
A new scoring system identifies patients at higher risk of neurotoxicity after CAR T-cell therapy, which may prevent the need for routine prolonged hospitalization for observation.
-
Circulating Blood Counts Predict Response, Survival in Recurrent Glioblastoma Treated with Bevacizumab
Massachusetts General Hospital researchers are the first to report that changes in eosinophil, lymphocyte and platelet counts might serve as biomarkers of clinical outcomes in patients with recurrent glioblastoma who are treated with bevacizumab.
-
Novel Combination Therapy Highly Effective Against IDH-mutant Glioma
Adding a poly(ADP-ribose) glycohydrolase inhibitor to temozolomide was highly effective in glioma cell lines and an IDH-mutant xenograft mouse model.
Neurosurgery contributors
-
Aman B. Patel, MD
Director of Cerebrovascular and Endovascular Neurosurgery, Co-Director of the Neuroendovascular Program
Recent Article
Stroke-Risk, COVID-19 and When to Seek Emergency Care
-
Bob S. Carter, MD, PhD
Chief, Neurosurgery Service
Recent Article
Gene Fusions Detected in Plasma of Glioblastoma Patients, Suggesting New Approach to Liquid Biopsy
-
Brian V. Nahed, MD, MSc
Neurosurgical Oncology / Brain Tumor Surgeon / Mass General Brain Tumor Center, Neurosurgical Spinal Disorders, Associate Professor, Harvard Medical School
Associate Director Mass General Neurosurgery ProgramRecent Article
Circulating Blood Counts Predict Response, Survival in Recurrent Glioblastoma Treated with Bevacizumab
-
Daniel P. Cahill, MD, PhD
Neurosurgeon
Recent Article
Novel Combination Therapy Highly Effective Against IDH-mutant Glioma
-
James D. Rabinov, MD
Neurosurgeon
Recent Article
Multimodal Approach to Unruptured Cerebral Arteriovenous Malformations Tops ARUBA Outcomes
-
Jean V. Coumans, MD
Neurosurgeon
Recent Article
Sacral Slope Measurement Helpful for Determining if Fusion Surgery Needed for Spondylolisthesis
-
Jeffrey S. Schweitzer, MD, PhD
Neurosurgeon
Recent Article
Patient-derived Dopamine Neurons Show Promise in Parkinson's Treatment
-
John H. Shin, MD
Director, Spinal Deformity and Spine Oncology (Mass General Cancer Center), Spinal Reconstruction Surgery
Recent Article
Advanced Technology Improves Cervical Spine Surgery Outcomes
-
-
Lawrence Borges, MD
Director, Neurosurgical Spine Center
Recent Article
Treating Intradural Spinal Tumors
-
Pamela S. Jones, MD
Neurosurgeon
Recent Article
Liquid Biopsy Using Fluorescent Extracellular Vesicles Shows Promise for Diagnosis of Glioma
-
William E. Butler, MD
Neurosurgeon
Recent Article
Recurrent Basilar Tip Pseudoaneurysm Treated Successfully with Flow Diversion
-
William T. Curry, MD
Co-Director, Mass General Neuroscience , Director of Neurosurgical Oncology
Recent Article
Endonasal Surgery Using High-Speed Drill Puts Health Care Team at Risk of COVID-19
-
Ziv Williams, MD
Associate Professor in Neurosurgery
Recent Article
Spine Surgeon Specialty Does Not Influence Short-term Outcomes of Percutaneous Kyphoplasty
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.Resource Links
